Abetalipoproteinemia is a genetic disorder that interferes with the intestines’ ability to absorb fats, cholesterol, and fat-soluble vitamins. Due to their lipid and vitamin deficiencies, people with this condition develop progressive symptoms that affect many important functions, predominantly vision, blood low, and the nervous and gastrointestinal systems. With early diagnosis and treatment, physicians can combat abetalipoproteinemia’s progression and improve prognosis.
Abetalipoproteinemia is the result of mutations in the MTTP gene, which provides instructions for making MTP proteins that help create beta-lipoproteins that transport cholesterol, fats, and fat-soluble vitamins from the intestine and through the bloodstream for various tissues to absorb. The mutations render the body unable to create MTP proteins, without which the body cannot transport the nutrients; deficiencies develop, leading to health problems.
This site offers information designed for educational purposes only. You should not rely on any information on this site as a substitute for professional medical advice, diagnosis, treatment, or as a substitute for, professional counseling care, advice, diagnosis, or treatment. If you have any concerns or questions about your health, you should always consult with a physician or other healthcare professional.